Last reviewed · How we verify
LISTERINE COOL MINT Antiseptic Mouthwash
LISTERINE COOL MINT Antiseptic Mouthwash is a Antiseptic mouthwash Small molecule drug developed by Johnson & Johnson Consumer Inc. (J&JCI). It is currently FDA-approved for Reduction of plaque and gingivitis, Bad breath control, General oral antisepsis.
Listerine Cool Mint kills oral bacteria and reduces plaque formation through its essential oil and alcohol active ingredients.
Listerine Cool Mint kills oral bacteria and reduces plaque formation through its essential oil and alcohol active ingredients. Used for Reduction of plaque and gingivitis, Bad breath control, General oral antisepsis.
At a glance
| Generic name | LISTERINE COOL MINT Antiseptic Mouthwash |
|---|---|
| Sponsor | Johnson & Johnson Consumer Inc. (J&JCI) |
| Drug class | Antiseptic mouthwash |
| Modality | Small molecule |
| Therapeutic area | Oral Health / Dentistry |
| Phase | FDA-approved |
Mechanism of action
The mouthwash contains a combination of essential oils (eucalyptol, menthol, methyl salicylate, thymol) and alcohol that work as antimicrobial agents to disrupt bacterial cell membranes and inhibit microbial growth in the oral cavity. This reduces plaque accumulation, gingivitis, and bad breath by eliminating odor-causing bacteria.
Approved indications
- Reduction of plaque and gingivitis
- Bad breath control
- General oral antisepsis
Common side effects
- Oral irritation or burning sensation
- Tooth staining (with prolonged use)
- Allergic reaction (rare)
Key clinical trials
- Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention (PHASE2)
- A Study of Experimental Mouthwashes (PHASE4)
- A Study of Virtually Supervised Mouthwash and Interdental Brushes (PHASE4)
- A Two-Week Study of Clinical Safety and Saliva Flow Quantification (PHASE4)
- A Twelve Week Study of Prototypes Mouth Rinses (PHASE4)
- A Study of Virtually Supervised Mouth Rinses and Flossing (PHASE4)
- A Twelve Week Study of Virtually Supervised Mouth Rinse and Flossing (PHASE4)
- A Clinical Trial to Test the Effect of Marketed Mouth Rinses on Decreasing Plaque and Gum Inflammation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LISTERINE COOL MINT Antiseptic Mouthwash CI brief — competitive landscape report
- LISTERINE COOL MINT Antiseptic Mouthwash updates RSS · CI watch RSS
- Johnson & Johnson Consumer Inc. (J&JCI) portfolio CI
Frequently asked questions about LISTERINE COOL MINT Antiseptic Mouthwash
What is LISTERINE COOL MINT Antiseptic Mouthwash?
How does LISTERINE COOL MINT Antiseptic Mouthwash work?
What is LISTERINE COOL MINT Antiseptic Mouthwash used for?
Who makes LISTERINE COOL MINT Antiseptic Mouthwash?
What drug class is LISTERINE COOL MINT Antiseptic Mouthwash in?
What development phase is LISTERINE COOL MINT Antiseptic Mouthwash in?
What are the side effects of LISTERINE COOL MINT Antiseptic Mouthwash?
Related
- Drug class: All Antiseptic mouthwash drugs
- Manufacturer: Johnson & Johnson Consumer Inc. (J&JCI) — full pipeline
- Therapeutic area: All drugs in Oral Health / Dentistry
- Indication: Drugs for Reduction of plaque and gingivitis
- Indication: Drugs for Bad breath control
- Indication: Drugs for General oral antisepsis
- Compare: LISTERINE COOL MINT Antiseptic Mouthwash vs similar drugs
- Pricing: LISTERINE COOL MINT Antiseptic Mouthwash cost, discount & access